Zoetis Inc. (NYSE:ZTS) EVP Roxanne Lagano Sells 326 Shares

Zoetis Inc. (NYSE:ZTS) EVP Roxanne Lagano sold 326 shares of Zoetis stock in a transaction on Tuesday, February 11th. The stock was sold at an average price of $171.18, for a total transaction of $55,804.68. Following the sale, the executive vice president now owns 16,107 shares in the company, valued at $2,757,196.26. This represents a 1.98 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

Zoetis Price Performance

ZTS opened at $173.99 on Thursday. The company has a debt-to-equity ratio of 1.26, a current ratio of 3.69 and a quick ratio of 2.27. The company’s 50 day simple moving average is $169.11 and its 200-day simple moving average is $179.11. Zoetis Inc. has a one year low of $144.80 and a one year high of $200.53. The stock has a market capitalization of $78.50 billion, a P/E ratio of 32.70, a price-to-earnings-growth ratio of 2.77 and a beta of 0.90.

Zoetis Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Tuesday, June 3rd. Stockholders of record on Monday, April 21st will be given a dividend of $0.50 per share. The ex-dividend date is Monday, April 21st. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.15%. Zoetis’s payout ratio is currently 37.59%.

Hedge Funds Weigh In On Zoetis

Several large investors have recently made changes to their positions in ZTS. Norges Bank bought a new stake in Zoetis during the 4th quarter worth about $824,321,000. Mizuho Securities USA LLC grew its position in shares of Zoetis by 13,726.9% during the 3rd quarter. Mizuho Securities USA LLC now owns 4,865,000 shares of the company’s stock worth $950,524,000 after buying an additional 4,829,815 shares during the period. Wellington Management Group LLP raised its stake in shares of Zoetis by 78.5% during the fourth quarter. Wellington Management Group LLP now owns 6,958,543 shares of the company’s stock worth $1,133,755,000 after buying an additional 3,059,255 shares during the last quarter. Raymond James Financial Inc. acquired a new position in Zoetis in the fourth quarter valued at approximately $196,651,000. Finally, Polen Capital Management LLC boosted its stake in Zoetis by 17.5% in the fourth quarter. Polen Capital Management LLC now owns 7,483,194 shares of the company’s stock valued at $1,219,237,000 after acquiring an additional 1,116,541 shares during the last quarter. Institutional investors and hedge funds own 92.80% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities research analysts have weighed in on ZTS shares. Leerink Partnrs raised Zoetis to a “strong-buy” rating in a report on Monday, December 2nd. Morgan Stanley decreased their price target on Zoetis from $248.00 to $243.00 and set an “overweight” rating on the stock in a research note on Wednesday, January 29th. Stifel Nicolaus dropped their price objective on Zoetis from $210.00 to $180.00 and set a “buy” rating for the company in a research note on Tuesday, January 7th. Piper Sandler cut their price objective on Zoetis from $210.00 to $200.00 and set an “overweight” rating for the company in a report on Monday. Finally, Leerink Partners began coverage on shares of Zoetis in a report on Monday, December 2nd. They issued an “outperform” rating and a $215.00 target price on the stock. One equities research analyst has rated the stock with a hold rating, ten have assigned a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Buy” and a consensus price target of $214.00.

Zoetis Company Profile

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.